| Revision as of 08:38, 6 August 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[Misplaced Pages:WikiProject Chemicals/Chembox validation|Chem/← Previous edit |
Latest revision as of 16:57, 15 January 2025 edit undoFswitzer4 (talk | contribs)Extended confirmed users10,998 editsm Added CAS RN |
| (17 intermediate revisions by 11 users not shown) |
| Line 1: |
Line 1: |
|
|
{{short description|Chemical compound}} |
|
{{Drugbox |
|
|
|
{{Infobox drug |
| ⚫ |
| verifiedrevid = 443313080 |
|
|
|
| Watchedfields = changed |
| ⚫ |
| IUPAC_name = 1-(2-methyl-1H-indol-3-yl)propan-2-amine |
|
|
⚫ |
| verifiedrevid = 443314047 |
|
⚫ |
| IUPAC_name = 1-(2-methyl-1''H''-indol-3-yl)propan-2-amine |
|
| image = 2,a-DMT.svg |
|
| image = 2,a-DMT.svg |
|
| width = 200 |
|
| width = 200 |
|
| image2 = 2,alpha-DMT_3d_structure.png |
|
| image2 = 2,alpha-DMT_3d_structure.png |
|
|
<!--Clinical data--> |
|
| width = 200 |
|
|
|
| tradename = |
| ⚫ |
| CASNo_Ref = {{cascite|correct|CAS}} |
|
|
| CAS_number = 4966-28-3 |
|
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
⚫ |
| pregnancy_US = <!-- A / B / C / D / X --> |
| ⚫ |
| ATC_prefix = |
|
|
⚫ |
| pregnancy_category = |
| ⚫ |
| ATC_suffix = |
|
|
⚫ |
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
|
⚫ |
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
⚫ |
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
|
⚫ |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
⚫ |
| legal_status = |
|
⚫ |
| routes_of_administration = |
|
|
<!--Pharmacokinetic data--> |
|
⚫ |
| bioavailability = |
|
⚫ |
| protein_bound = |
|
⚫ |
| metabolism = |
|
⚫ |
| elimination_half-life = |
|
⚫ |
| excretion = |
|
|
<!--Identifiers--> |
|
⚫ |
| CAS_number_Ref = {{cascite|correct|CAS}} |
|
|
| CAS_number = 4966-28-3 |
|
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
|
| UNII = QAH3JR2679 |
|
⚫ |
| ATC_prefix = |
|
⚫ |
| ATC_suffix = |
|
⚫ |
| PubChem = |
|
⚫ |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
⚫ |
| DrugBank = |
|
⚫ |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
⚫ |
| ChemSpiderID = 23511903 |
|
|
<!--Chemical data--> |
|
⚫ |
| chemical_formula = |
|
|
| C=12 | H=16 | N=2 |
|
⚫ |
| molecular_weight = |
|
⚫ |
| smiles = Cc1c(c2ccccc21)CC(C)N |
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI = 1S/C12H16N2/c1-8(13)7-11-9(2)14-12-6-4-3-5-10(11)12/h3-6,8,14H,7,13H2,1-2H3 |
|
| StdInChI = 1S/C12H16N2/c1-8(13)7-11-9(2)14-12-6-4-3-5-10(11)12/h3-6,8,14H,7,13H2,1-2H3 |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey = AXZQFXRPULJFQK-UHFFFAOYSA-N |
|
| StdInChIKey = AXZQFXRPULJFQK-UHFFFAOYSA-N |
| ⚫ |
| PubChem = |
|
| ⚫ |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ⚫ |
| ChemSpiderID = 23511903 |
|
| ⚫ |
| smiles = Cc1c(c2ccccc21)CC(C)N |
|
|
| InChI = 1S/C12H16N2/c1-8(13)7-11-9(2)14-12-6-4-3-5-10(11)12/h3-6,8,14H,7,13H2,1-2H3 |
|
| ⚫ |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
| ⚫ |
| DrugBank = |
|
| ⚫ |
| chemical_formula =|C=12|H=16|N=2 |
|
| ⚫ |
| molecular_weight = |
|
| ⚫ |
| bioavailability = |
|
| ⚫ |
| protein_bound = |
|
| ⚫ |
| metabolism = |
|
| ⚫ |
| elimination_half-life = |
|
| ⚫ |
| excretion = |
|
|
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
| ⚫ |
| pregnancy_US = <!-- A / B / C / D / X --> |
|
| ⚫ |
| pregnancy_category= |
|
| ⚫ |
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
|
| ⚫ |
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
| ⚫ |
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
|
| ⚫ |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
| ⚫ |
| legal_status = |
|
| ⚫ |
| routes_of_administration = |
|
|
}} |
|
}} |
|
|
|
|
|
'''2,alpha-DMT''', or '''2,α-dimethyltryptamine''', is a ] and a lesser-known ]. It is the 2,a-di] ] of ]. 2,α-DMT was first synthesized by ]. In his book '']'' (''Tryptamines I Have Known and Loved''), Shulgin lists the dosage as 300-500 ], and the duration as 7-10 hours.<ref>{{CiteTiHKAL|pages=422}}</ref> 2,α-DMT causes ] and ]. It also produces a calm, ]-like feeling. Very little data exists about the pharmacological properties, metabolism, and toxicity of 2,α-DMT. |
|
'''2,α-Dimethyltryptamine''' ('''2,α-DMT''') is a ] and a lesser-known ]. It is the 2,α-di] ] of ]. Its synthesis was first reported in 1965.<ref>{{cite journal | vauthors = Heath-Brown B, Philpott PG |title=Studies in the Indole Series. Part I. Indolylalkylamines |journal=Journal of the Chemical Society |date=1965 |issue=Dec |pages=7165–7178|doi=10.1039/jr9650007165 }}</ref> ] lists the dosage as 300-500 ], and the duration as 7–10 hours in his book '']'' (''Tryptamines I Have Known and Loved'').<ref>{{CiteTiHKAL|pages=422|name-list-style = vanc }}</ref> 2,α-DMT causes ] and ]. It also produces a calm, ]-like feeling. Very little data exists about the pharmacological properties, metabolism, and toxicity of 2,α-DMT. |
|
|
|
|
|
==References== |
|
==References== |
| Line 45: |
Line 53: |
|
|
|
|
|
==External links== |
|
==External links== |
|
|
|
|
* |
|
* |
|
* |
|
* |
|
|
|
|
|
{{TiHKAL}} |
|
{{Tryptamines}} |
|
|
|
|
|
{{DEFAULTSORT:DMT, 2,alpha-}} |
|
{{DEFAULTSORT:DMT, 2, alpha-}} |
|
|
|
|
|
] |
|
] |
|
] |
|
|
|
|
|
|
|
|
{{Psychoactive-stub}} |
|
{{Psychoactive-stub}} |